Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Kelsey Zhu

Autonomous Research · covers Industrials, Financial Services

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q3 (8 quarters).

Questions
34on tracked calls
Challenge rate
6%2 of 34 questions
Companies
4questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 34 of 34 questions from 4 companies

EFXEquifax13 questions · 7 reporting periods · 0 of 13 challenging
EFX company page →

Calendar 2026 Q2

Any thoughts around the timeline for full-scale implementation for both VantageScore and FICO 10T?

Competitive DynamicsRegulation PolicyProduct LaunchTranscript · FY2026 Q2 →
Show response

Management sees strong Vantage momentum, still gated to 20+ lenders, expected to expand.

Calendar 2026 Q1

Got it. Second question, I was wondering if you can talk a little bit more about your outlook for volume growth across c

CreditGuidance ReliabilityRevenue GrowthTranscript · FY2026 Q1 →
Show response

Management addressed the question directly with specific data points.

Could you maybe talk a little bit more about your expectation around VantageScore market share gains and future pricing

Cloud & AICompetitive DynamicsCreditTranscript · FY2026 Q1 →
Show response

Management addressed the question directly with specific data points.

Calendar 2025 Q4

Got it. So second question, understanding that you are EBITDA agnostic on the cycle direct program, but it does impact r

Cloud & AICompetitive DynamicsGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Management addressed the question directly with specific data points.

Hi, good morning. Thanks for taking my question. Some of your peers have called out the improvement in the underlying po

CreditDemandGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Management addressed the question directly with specific data points.

Calendar 2025 Q3

You cited VantageScore upside in the mortgage vertical, which was very helpful.

Competitive DynamicsCreditPricingTranscript · FY2025 Q3 →
Show response

Management addressed the question directly with specific data points.

Got it. And then second question on the Government vertical.

CreditGuidance ReliabilityProduct LaunchTranscript · FY2025 Q3 →
Show response

Management addressed the question directly with specific data points.

Calendar 2025 Q2

Hi. Good morning. Thanks for taking my question. I have two questions on government vertical.

Cloud & AICost PressureInnovation & R&DTranscript · FY2025 Q2 →
Show response

Management addressed the question directly with specific data points.

Got it. Super helpful. And just more broadly, Mark, I was wondering if you can help us think through the opioid aid impa

Cloud & AIInnovation & R&DRegulation PolicyTranscript · FY2025 Q2 →
Show response

Management addressed the question directly with specific data points.

Calendar 2025 Q1

Good morning, thanks for taking my question. I found the recession scenario analysis super helpful.

Guidance ReliabilityMacroeconomicRevenue GrowthTranscript · FY2025 Q1 →
Show response

Management addressed the question directly with specific data points.

I was wondering how you expect each of these components to grow under a stagflation environment, meaning muted growth an

Cloud & AICreditInnovation & R&DTranscript · FY2025 Q1 →
Show response

Management addressed the question directly with specific data points.

Calendar 2024 Q4

Hi, thanks for taking my question. I want to talk about the SSA contract extension that you've announced at the end of Q

Regulation PolicyRevenue GrowthTranscript · FY2024 Q4 →
Show response

Management addressed the question directly with specific data points.

Thanks. I was also wondering if you have any updated thoughts on sizing the incremental record additions from the Workda

Cloud & AIInnovation & R&DRevenue GrowthTranscript · FY2024 Q4 →
Show response

Management addressed the question directly with specific data points.

FDSFactSet7 questions · 7 reporting periods · 1 of 7 challenging
FDS company page →

Calendar 2026 Q3

Could you talk a little bit more about your acquisition of BCC Group and how it fits into your overall strategy?

Show response

Framed BCC as a high-operating-leverage technology unlock for real-time data distribution, explicitly not a services business.

Calendar 2026 Q2

how should we think about the incremental revenue opportunities brought by MCP

Cloud & AIRevenue GrowthSubscriber GrowthTranscript · FY2026 Q3 →
Show response

Mgmt said MCP is bringing net-new users (~20% of endpoint users) and AI consumption is upsizing existing products, an early AI flywheel effect.

Calendar 2026 Q1

If you transition all of your workstation ASV into Data Solutions ASV and apply usage-based pricing on top of that, what would that look like? Because I think end users are using FactSet Research S...

Show response

Sanoke said all channels are growing with user personas expanding beyond traditional workstation users to tech and data science teams. Enterprise contracts restructured for flexibility across workstation, feeds, MCP, and future channels. Over 30% extension in enterprise contract lengths.

Calendar 2025 Q4

I feel like recently there's been a lot of discussion around FactSet's competitive positioning versus AI startups. I'm actually more curious to hear your perspective on how FactSet is positioned am...

ChallengingCompetitive DynamicsCloud & AITranscript · FY2026 Q1 →
Show response

Sanoke expressed strong confidence in proprietary data and analytics assets, noting active partnerships across the AI ecosystem from hyperscalers to startups. Highlighted workstation as secure distribution channel for AI consumption.

Calendar 2025 Q3

how does that compare to guidance? And if you're expecting the same type of growth from AI products in 2026?

Cloud & AIRevenue GrowthTranscript · FY2025 Q4 →
Show response

Helen confirmed GenAI contribution landed exactly at midpoint (40 bps) of 30-50 bps guidance. Noted these are stand-alone monetized products but AI influence on client decisions is much broader. Goran added 60% of AI sales came in Q4, and 35% of renewals cited GenAI as contributor.

Calendar 2025 Q1

I was wondering if you can provide more colors around the traction you’ve been gaining with clients, especially when it comes to PitchCreator and some of the other Gen AI products that you piloted ...

Show response

Phil highlighted PitchCreator as most momentum with almost two dozen large banking client trials. Conversational API seeing traction across all firm types. Portfolio Commentary packaging improving. Goran confirmed clients reacting well to pricing structure.

Calendar 2024 Q4

if we have any updated thoughts on total addressable market, who the key competitors are in this space, and just generally your strategy to expand

Competitive DynamicsDemandTranscript · FY2025 Q1 →
Show response

Phil highlighted Q1 outsourced CIO win and JPMorgan partnership. Goran noted no direct competition exists. Helen added attach rates are strong.

MSCIMSCI7 questions · 7 reporting periods · 1 of 7 challenging
MSCI company page →

Calendar 2026 Q2

Analytics margin was a bit softer than expected this quarter. Could you maybe talk about the main drivers there

ChallengingMarginCost PressureTranscript · FY2026 Q2 →
Show response

Andy downplayed one-quarter segment margins, citing a prior-year Fabric contingent-consideration reversal and elevated comp and performance-stock accruals as skewing the comparison.

Calendar 2026 Q1

Good morning. Thanks for taking my question. How does AI change the competitive dynamics for you, particularly for the Analytics business? Are you seeing any intensified competition there?

Competitive DynamicsCloud & AIProduct LaunchTranscript · FY2026 Q1 →
Show response

Management addressed the question with specific commentary.

Calendar 2025 Q4

On ESG, I guess, a while ago, we talked about the regulatory headwinds or regulatory uncertainty in Europe and how that's impacted growth. What are you seeing in that market more recently?

Geographic ExpansionProduct LaunchRegulation PolicyTranscript · FY2025 Q4 →
Show response

Management addressed the question with specific commentary.

Calendar 2025 Q3

On active ETFs, could you just talk a little bit more about the economics of the products and services you provide in that area as well as your competitive advantages?

Revenue GrowthCompetitive DynamicsProduct LaunchTranscript · FY2025 Q3 →
Show response

Management addressed the question with specific commentary.

Calendar 2025 Q2

Hi, good morning. Thanks for taking my question. Henry, I'm glad you mentioned active ETFs a few times in prepared remarks and in the Q&A.

Revenue GrowthProduct LaunchMacroeconomicTranscript · FY2025 Q2 →
Show response

Management addressed the question with specific commentary.

Calendar 2025 Q1

Hi, good morning. Thanks for taking my question. Just on analytics, I think you previously highlighted that in a period of high volatility and uncertainty, analytics would generally see

Show response

Management addressed the question with specific commentary.

Calendar 2024 Q4

Hi, good morning. Thanks for taking my question. So in private assets this quarter I think we’ve seen declines in both retention rates and net new sales.

Subscriber GrowthM&AProduct LaunchTranscript · FY2024 Q4 →
Show response

Management addressed the question with specific commentary.

VRSKVerisk7 questions · 7 reporting periods · 0 of 7 challenging
VRSK company page →

Calendar 2026 Q2

are you also looking at partnering with some of these AI companies for model co-development?

Cloud & AIInnovation & R&DCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Shavel confirmed engagement across all frontier model companies and framed Verisk's last-mile workflow distribution as the key asset they value.

Calendar 2026 Q1

Where do you see

Show response

Elizabeth Mann declined to size AI revenue impact, noting efficiency gains on development and data ingestion are offset by AI investment spending, calling it a 'push on the margin.' Lee Shavel cited productivity improvement as the primary monetization path.

Calendar 2025 Q4

Was wondering if you can talk a little bit more about any recent changes to the broader selling environment or sales cycle that you are seeing as P&C insurance industry transitions from hard to sof...

DemandPricingMacroeconomicTranscript · FY2025 Q4 →
Show response

Lee Shavel noted lower premium growth motivates carriers to use more tools for profitable growth and risk assessment, and heightened profitability gives them resources to invest.

Calendar 2025 Q3

You called out the competitive pressure in auto 2 quarters in a row now. So I was just wondering if you can give us an update on what is happening in that market

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q3 →
Show response

Elizabeth Mann confirmed no change from prior quarter, noting focus on product differentiation through deeper data sets and unique analytic capabilities.

Calendar 2025 Q2

I think you called out a couple of times the competitive pressure there. So I was just wondering if you can add more color who you're seeing these competitive pressures from

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q2 →
Show response

Lee Shavel acknowledged a large-scale competitor without naming them, noting auto is less than 10% of total business and they compete by tying claims data to underwriting data.

Calendar 2025 Q1

You called out strong pricing realization in forms, rules, loss cost. I was just wondering what's contributing to trends you're seeing there

PricingRevenue GrowthTranscript · FY2025 Q1 →
Show response

Elizabeth Mann cited both Core Lines Reimagine value delivery and strong 2023 premium growth (over 10%, around 11%) as contributing factors to pricing realization.

Calendar 2024 Q4

20% to 25% of your revenues come from contracts that have a direct input of premium growth with a 2-year lag. And 2023 was a pretty strong year for premium growth

PricingRevenue GrowthTranscript · FY2024 Q4 →
Show response

Elizabeth Mann confirmed the premium-linked dynamic continues but redirected focus to value-based pricing as the more important long-term driver, without quantifying the specific pricing contribution.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
EFX Equifax130%none of 13 questions
FDS FactSet714%1 of 7 questions
MSCI MSCI714%1 of 7 questions
VRSK Verisk70%none of 7 questions
  • EFX
    Equifax · 13 questions
    0%none of 13 questions
  • FDS
    FactSet · 7 questions
    14%1 of 7 questions
  • MSCI
    MSCI · 7 questions
    14%1 of 7 questions
  • VRSK
    Verisk · 7 questions
    0%none of 7 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q450%none of 5 questions4
2025 Q150%none of 5 questions4
2025 Q240%none of 4 questions3
2025 Q350%none of 5 questions4
2025 Q4520%1 of 5 questions4
2026 Q150%none of 5 questions4
2026 Q2425%1 of 4 questions4
2026 Q310%none of 1 question1
  1. 2024 Q45 questions · challenge rate 0% (none of 5 questions) · 4 companies
  2. 2025 Q15 questions · challenge rate 0% (none of 5 questions) · 4 companies
  3. 2025 Q24 questions · challenge rate 0% (none of 4 questions) · 3 companies
  4. 2025 Q35 questions · challenge rate 0% (none of 5 questions) · 4 companies
  5. 2025 Q45 questions · challenge rate 20% (1 of 5 questions) · 4 companies
  6. 2026 Q15 questions · challenge rate 0% (none of 5 questions) · 4 companies
  7. 2026 Q24 questions · challenge rate 25% (1 of 4 questions) · 4 companies
  8. 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Cloud & AI14
  • Revenue Growth13
  • Competitive Dynamics11
  • Product Launch8
  • Pricing6
  • Credit6
  • Innovation & R&D5
  • Guidance Reliability5
  • Regulation Policy4
  • Demand3
Show all 16 topics
  • Macroeconomic3
  • M&A2
  • Subscriber Growth2
  • Margin2
  • Cost Pressure2
  • Geographic Expansion1